{"nct_id":"NCT02302339","title":"A Study of Glembatumumab Vedotin as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma","status":"TERMINATED","status_verified_date":"2019-08","start_date":"2014-11","start_date_type":null,"primary_completion_date":"2018-06-14","primary_completion_date_type":"ACTUAL","completion_date":"2018-10-03","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["CLDX"]}